Healthcare Finance News September 5, 2024
While retail pharmacy prices rose 9.1% from 2007 to 2020, negotiated prices grew by only 4.3% annually.
Speaking to a lack of transparency in pharmaceutical pricing, a new Health Affairs study has found that, over time, out-of-pocket drug prices for consumers have grown more quickly than those encountered by insurers.
Examining the role that rebates negotiated by pharmacy benefit managers play in drug pricing, researchers at the Bureau of Economics compared rebate estimates with claims data over a 13-year period from 2007 to 2020.
They found that while retail pharmacy prices rose 9.1% each year, negotiated prices grew by only 4.3% annually, though consumer out-of-pocket spending grew by 5.8% over that period.
WHAT’S THE IMPACT?
Rebates for drug prices, which...
Today's Sponsors
Today's Sponsor